Storage and Handling: What the Labels and the Chemistry Say

A peptide is a chain of amino acids joined by amide bonds, often with additional structure layered on top: disulfide bridges between cysteine residues, a cyclic backbone, or a chemical modification such as acylation. Where a peptide ends and a protein begins is a matter of convention rather than chemistry, with the line usually drawn somewhere around 40 to 50 residues. What matters for storage is that biological recognition depends on the molecule arriving intact. Degradation does not have to shred the chain to matter. A single altered residue in the wrong place changes charge, shape, or both.

The chemical routes are well characterized. Hydrolysis splits the amide backbone, with water acting as the reactant and the rate rising sharply at pH extremes. Deamidation converts asparagine and glutamine side chains into acidic residues, and in the asparagine case it proceeds through a succinimide intermediate that can open to either aspartate or isoaspartate, quietly introducing a structural isomer with the same mass. Oxidation turns methionine into methionine sulfoxide and attacks cysteine, tryptophan and histidine. Disulfide bonds can scramble and re-form in the wrong pairing.

Physical degradation runs in parallel. Molecules can aggregate into dimers, higher oligomers and eventually visible particles, and in regulated biologics aggregate content is tracked closely because aggregates are the species most associated with unwanted immune responses. At low concentrations, peptides also adsorb onto glass and plastic surfaces, which is why formulations frequently include a surfactant such as polysorbate 20 or polysorbate 80. None of these processes announce themselves. A solution can look unchanged while its composition has shifted.

Lyophilisation is freeze drying. The formulated solution is frozen, then water is removed by sublimation under vacuum in a primary drying stage, and finally more tightly bound water is driven off in a secondary drying stage. The output is a cake rather than a milled powder, and cake appearance is part of the release specification, because collapse or meltback signals that the process ran above the formulation's critical temperature.

The point of all that effort is to remove water and molecular mobility at the same time. Hydrolysis and deamidation both require water, and most degradation requires molecules to move. In a properly dried cake the material sits in an amorphous glass below its glass transition temperature, where mobility is very low. Excipients do specific jobs here: sucrose or trehalose act as lyoprotectants and hydrogen bond in place of the removed water, mannitol is commonly used as a bulking agent to give the cake structure, buffer salts hold pH, and a surfactant limits interfacial damage. Residual moisture is measured, often by Karl Fischer titration, because even a small increase plasticises the glass and lowers the temperature at which it stops protecting anything.

Reconstitution is the reverse step: a liquid diluent is added back to the cake. It restores water and mobility, and it restarts every pathway that drying suppressed. This is why labels treat the dried form and the reconstituted form as two different products with two different storage statements and two different in-use periods. It is also why single-dose and multi-dose presentations are labeled differently. A presentation intended for repeated entry is formulated and tested for that, and a single-dose presentation is not, which is why the two carry different in-use statements. Which diluent and which period apply to any specific product is stated on that product's label and is a question for the prescribing clinician or pharmacist.

Reaction rates rise exponentially with temperature, following the Arrhenius relationship. A rough working approximation used across pharmaceutical stability work is that rates double to triple for every 10 degrees Celsius increase, which is why storage terminology is defined numerically rather than descriptively. In the USP General Notices, cold means 2 to 8 degrees Celsius, a freezer means roughly minus 25 to minus 10, and controlled room temperature means 20 to 25 with permitted excursions between 15 and 30. Mean kinetic temperature is a related concept worth knowing: it is a single computed temperature that captures the cumulative effect of a varying thermal history, weighted so that warm excursions count for more than a simple average would suggest.

Colder is not automatically better once a solution crosses into freezing. As ice forms it excludes solutes, concentrating whatever remains into a shrinking unfrozen fraction. In sodium phosphate buffers the disodium form crystallises out preferentially and the pH of the remaining liquid can fall by several units. The expanding ice and water interface is itself a denaturing surface, and some peptides and proteins undergo cold denaturation independently of freezing damage. Repeated freeze and thaw cycles compound all of it. That is the reasoning behind the instructions on many reconstituted biologic labels to avoid freezing and to discard product that has frozen.

How much temperature deviation a given product tolerates is a property of that product, established by testing, not something that can be reasoned out from the class. Manufacturers only claim what their stability data supports, and they claim it for the exact formulation and container they tested.

Light is a genuine degradation pathway, not a superstition. Tryptophan, tyrosine, phenylalanine and disulfide bonds absorb ultraviolet light directly, and tryptophan photo-oxidation generates products such as N-formylkynurenine and kynurenine. Indirect damage matters too: trace photosensitisers, including riboflavin and certain excipient impurities, absorb light and generate reactive oxygen species that then oxidise methionine and other residues nearby. Amber glass, opaque cartons and the phrase protect from light all trace back to this.

When a label carries a light instruction, it is reporting a test result. ICH Q1B is the international guideline that defines photostability testing, specifying exposure of not less than 1.2 million lux hours of visible light together with not less than 200 watt hours per square metre of near ultraviolet energy, run on the product both directly and in its marketed packaging. The instruction on the carton is the conclusion of that study.

Air and movement round out the list. Headspace oxygen drives oxidation, which is why some products are filled under nitrogen, and trace metal ions catalyse it, which is why chelators such as EDTA appear in some formulations. Shaking creates air and liquid interfaces and foam, where molecules unfold and then aggregate. Instructions to avoid shaking and to handle gently are addressing that specific mechanism rather than fragility in general.

A complete storage statement has more parts than most people read. There is a numeric temperature condition, a light instruction, usually a freeze instruction, and an expiry date. There is also, crucially, a scope: the condition applies to an unopened container in its original closure, and a separate condition with its own shorter period applies after first entry or after reconstitution. Many labels also name the specific diluent the product was tested with.

Every one of those elements is tied to the exact configuration that was studied. The glass type, the elastomeric stopper, the fill volume and the headspace are all part of what was tested, because container and closure interactions are real. Borosilicate glass can delaminate under some conditions, stoppers contribute extractables and leachables, and silicone oil and residual tungsten from syringe manufacture have both been implicated in aggregation in the literature.

The practical consequence is simple to state. Once material is moved out of the container it was tested in, or combined with a diluent it was not tested with, the label's evidence no longer covers it. The instruction has not become wrong, it has become inapplicable, and nothing has replaced it.

An expiration date is set by a manufacturer from a formal stability programme. ICH Q1A(R2) describes the structure: long term real time storage at conditions matched to the intended climatic zone, such as 25 degrees Celsius and 60 percent relative humidity, alongside accelerated testing typically at 40 degrees and 75 percent relative humidity for six months, with intermediate conditions where accelerated results show significant change. The resulting date is a claim that the product will still meet its identity, strength, quality and purity specifications, provided it stayed unopened and stored as labeled.

A beyond-use date is a different instrument. It applies once the sterile barrier is broken, the product is reconstituted, or it is compounded, and it is generally far shorter. The driver is usually microbial contamination risk rather than chemical decay. In United States compounding practice, USP Chapter 797 governs beyond-use dating for compounded sterile preparations, and a multi-dose container entered in a clinical setting is assigned an in-use period under that standard and under the manufacturer's labeling. The principle matters more than any particular period: a beyond-use date belongs to one specific product in one specific setting, it is set by the people accountable for that setting, and it does not transfer to anything else.

Material sold for laboratory use sits outside this system entirely. It is labeled as not for human consumption, and it carries no approved storage statement, no ICH stability package, and no expiry date with regulatory meaning behind it. A certificate of analysis does not fill that gap either. It reports purity and identity at the moment of testing, which is a snapshot, and it says nothing about how the material behaves weeks or months later under any set of conditions. The absence of stability data is a fact about the material rather than a blank to be filled in with assumption.

Nothing above is a substitute for a product's own label or for a licensed clinician. Whether a specific product is still appropriate to use, how it should be handled, and what to do if a storage condition was not met are all clinical questions, and they belong with the prescriber or the pharmacist who can see the actual product and the actual situation.

What is reasonable for anyone to do is keep an accurate record. What arrived and when, when a container was first entered, what the label states, and what conditions the material has actually been kept in. Chemical change is usually invisible, so a written history is more reliable than a recollection, and it is exactly the information a clinician will ask for.

That record keeping is the part OptimusPep is built for. Tracking dates, conditions and label details is documentation, not medical decision making, and keeping the documentation clean makes the clinical conversation a much shorter one.